Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

Delayed Quote. Delayed  - 09/23 05:35:24 pm
97.89 EUR   +0.06%
09/22 MERCK : and the Royal Health Awareness Society Partner to Advance Wo..
09/21 MERCK : Invests over € 50 million in Flagship Pharmaceutical Packagi..
09/21 GLOBAL AZO PIGM : Basf, Clariant, Lanxess, Eckart, EMD, Merck KGaA, ..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/19/2016 09/20/2016 09/21/2016 09/22/2016 09/23/2016 Date
96.12(c) 97.3(c) 96.73(c) 97.83(c) 97.89(c) Last
296 670 378 169 292 445 296 904 256 784 Volume
+1.19% +1.23% -0.59% +1.14% +0.06% Change
More quotes
Financials (€)
Sales 2016 15 041 M
EBIT 2016 3 285 M
Net income 2016 1 546 M
Debt 2016 10 800 M
Yield 2016 1,25%
Sales 2017 15 470 M
EBIT 2017 3 466 M
Net income 2017 1 722 M
Debt 2017 8 847 M
Yield 2017 1,34%
P/E ratio 2016 25,90
P/E ratio 2017 22,47
EV / Sales2016 1,56x
EV / Sales2017 1,39x
Capitalization 12 652 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises of the businesses that were reported separately as the Merck Serono and Consumer Health... 
Sector
Pharmaceuticals
Calendar
11/15Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
09/22 MERCK : and the Royal Health Awareness Society Partner to Advance Women's Health..
09/21 MERCK : Invests over € 50 million in Flagship Pharmaceutical Packaging Building ..
09/21 GLOBAL AZO PIGMENTS MARKET 2016 : Basf, Clariant, Lanxess, Eckart, EMD, Merck KG..
09/21 MERCK : Angola Receives 4 Million Praziquantel Tablets
09/20 MERCK : Prexton successfully completes phase 1 Parkinson's disease trial
09/19 MERCK : New Steritest™ Symbio Pump Accessories Enable Faster, Safer Steril..
09/16 MERCK : Presents New Data Examining Durable Efficacy with Investigational Cladri..
09/15 MERCK : Announces 2016 Recipients of € 1 Million Grant for Multiple Sclerosis In..
09/15 MERCK : Findings from Merck KGaA Broaden Understanding of Granular Matter Resear..
09/15 MERCK : "From Glitter to Glamour" – The Merck Pigment Innovation Ronastar®..
More news
Sector news : Specialty & Advanced Pharmaceuticals
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
08/19 ALPHA FROM EQUAL-WEIGHTING : A Look At Materials
08/10 Bristol's Opdivo Fall-Out Brings Others Into Play
08/05 Merck KGaA's (MKGAF) CEO Stefan Oschmann on Q2 2016 Results - Earnings Call T..
08/04 Merck KGaA reports Q2 results
07/18 Merck's marketing application for Cladribine tablets accepted for review in E..
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 104 €
Spread / Average Target 6,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA9.29%14 203
ABBVIE INC9.69%105 823
BIOGEN INC2.03%68 493
KYOWA HAKKO KIRIN CO L..-14.44%9 295
MALLINCKRODT PLC2.25%8 220
JAZZ PHARMACEUTICALS P..-9.51%7 699
More Results